Newsletter Subscribe
Enter your email address below and subscribe to our newsletter

AstraZeneca and GSK announced separate partnerships with China's Sino Biopharmaceutical on Wednesday, marking a flurry of cross-border pharmaceutical dealmaking even as U.S. lawmakers push to bring such transactions under national security review.